Balaji Amines shares soared 19.99% to ₹1,623.40 in early trade following the company's Q4FY26 results announcement. According to reports from NDTV Profit, the stock touched an intraday high of ₹1,623.40 and a low of ₹1,496.00 during the trading session.
The company delivered impressive fourth quarter results with consolidated net profit rising 57.6% year-on-year to ₹632 million in Q4FY26, compared to ₹401 million in the previous year. As reported by NDTV Profit, revenue increased 12.8% to ₹3.95 billion during the quarter, with the company's EBITDA rising 39.8% to ₹94.3 crore. The standout performance was driven by margin expansion to approximately 16.0% from 11.4% in the same quarter last year, representing a 480 basis points improvement.
The board declared a final dividend of ₹11 per share for the quarter, according to the company's announcement. This dividend declaration reflects the strong cash generation capabilities of the company during the fiscal year and demonstrates management's confidence in sustained profitability.
The results demonstrate profit growth at nearly 5x the rate of revenue growth, indicating the company's ability to optimize margins even in a moderate demand environment. According to SAHI, the divergence between revenue growth and profit growth reflects a structurally better margin profile that could lead to earnings upgrades if sustained. The company has successfully managed input cost pressures that plagued the chemical sector last year, with operational leverage kicking in as specialized products likely contributed more to the revenue mix.
The positive earnings surprise serves as a lead indicator for margin recovery in the specialty chemicals sector, suggesting that the worst of margin compression may be over for established players with dominant market shares. SAHI views these results as a strong validation of Balaji Amines' dominant market position in the methyl amines and ethyl amines space, with the company successfully harvesting returns from recent capacity additions. The results indicate stabilization in the pricing of key aliphatic amines compared to the volatility seen in previous quarters, confirming steady volume demand from end-user industries like pharma and agrochemicals.
